132 related articles for article (PubMed ID: 37114494)
21. A lipid metabolism-based prognostic risk model for HBV-related hepatocellular carcinoma.
Zhou L; Xia S; Liu Y; Ji Q; Li L; Gao X; Guo X; Yi X; Chen F
Lipids Health Dis; 2023 Apr; 22(1):46. PubMed ID: 37004044
[TBL] [Abstract][Full Text] [Related]
22. Disparity of Hepatocellular Carcinoma in Tumor Microenvironment-Related Genes and Infiltrating Immune Cells between Asian and Non-Asian Populations.
Huang LH; Hsieh TM; Huang CY; Liu YW; Wu SC; Chien PC; Hsieh CH
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440448
[TBL] [Abstract][Full Text] [Related]
23. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
Huang S; Zhang J; Lai X; Zhuang L; Wu J
Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
[No Abstract] [Full Text] [Related]
24. A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma.
Liu C; Wu Z; Wang L; Yang Q; Huang J; Huang J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292980
[TBL] [Abstract][Full Text] [Related]
25. Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making.
Shi Y; Wang Y; Yang R; Zhang W; Zhang Y; Feng K; Lv Q; Niu K; Chen J; Li L; Zhang Y
Front Endocrinol (Lausanne); 2022; 13():1090324. PubMed ID: 36605944
[TBL] [Abstract][Full Text] [Related]
26. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of m6A regulators associated with immune infiltration in Hepatitis B virus-related hepatocellular carcinoma.
Zhang Z; Gao W; Liu Z; Yu S; Jian H; Hou Z; Zeng P
BMC Gastroenterol; 2023 Jul; 23(1):259. PubMed ID: 37507670
[TBL] [Abstract][Full Text] [Related]
28. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.
Huang JH; Wang J; Chai XQ; Li ZC; Jiang YH; Li J; Liu X; Fan J; Cai JB; Liu F
Microbiol Spectr; 2022 Oct; 10(5):e0098322. PubMed ID: 36173308
[TBL] [Abstract][Full Text] [Related]
29. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.
Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R
Front Immunol; 2022; 13():990790. PubMed ID: 36248822
[TBL] [Abstract][Full Text] [Related]
30. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
[TBL] [Abstract][Full Text] [Related]
31. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.
Tang Y; Zhou H; Xiang Y; Cui F
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e167-e175. PubMed ID: 33208683
[TBL] [Abstract][Full Text] [Related]
32. An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment.
Wang J; Lou J; Fu L; Jin Q
J Int Med Res; 2021 Feb; 49(2):300060520980646. PubMed ID: 33567957
[TBL] [Abstract][Full Text] [Related]
33. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.
Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W
Front Immunol; 2020; 11():1037. PubMed ID: 32547550
[TBL] [Abstract][Full Text] [Related]
34. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis
Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J
Front Immunol; 2023; 14():1137025. PubMed ID: 37006257
[TBL] [Abstract][Full Text] [Related]
35. The Interaction between Intratumoral Microbiome and Immunity Is Related to the Prognosis of Ovarian Cancer.
Sheng D; Yue K; Li H; Zhao L; Zhao G; Jin C; Zhang L
Microbiol Spectr; 2023 Mar; 11(2):e0354922. PubMed ID: 36975828
[TBL] [Abstract][Full Text] [Related]
36. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
[TBL] [Abstract][Full Text] [Related]
37. A Six-Gene Prognostic Risk Prediction Model In Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Shen J; Shu M; Xie S; Yan J; Pan K; Chen S; Li X
Clin Invest Med; 2021 Oct; 44(3):E32-44. PubMed ID: 34600458
[TBL] [Abstract][Full Text] [Related]
38. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
[TBL] [Abstract][Full Text] [Related]
39. Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins.
Hayashi S; Nagaoka K; Tanaka Y
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681709
[TBL] [Abstract][Full Text] [Related]
40. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
